Skip to main content

Published locations for FDA Now Reviewing Panel's Nod to COX-2s : Celecoxib garnered nearly unanimous support; vote was more divided on rofecoxib and valdecoxib.

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA Now Reviewing Panel's Nod to COX-2s : Celecoxib garnered nearly unanimous support; vote was more divided on rofecoxib and valdecoxib.

User login

  • Reset your password
  • /content/fda-now-reviewing-panels-nod-cox-2s-celecoxib-garnered-nearly-unanimous-support-vote-was
  • /psychiatry/article/21402/health-policy/fda-now-reviewing-panels-nod-cox-2s-celecoxib-garnered-nearly
  • /clinicalpsychiatrynews/article/21402/health-policy/fda-now-reviewing-panels-nod-cox-2s-celecoxib